Form 8-K - Current report:
SEC Accession No. 0001193125-25-185355
Filing Date
2025-08-21
Accepted
2025-08-21 16:35:40
Documents
15
Period of Report
2025-08-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d912844d8k.htm   iXBRL 8-K 31502
2 EX-10.1 d912844dex101.htm EX-10.1 1027926
3 EX-99.1 d912844dex991.htm EX-99.1 12155
7 GRAPHIC g912844g0821063513088.jpg GRAPHIC 3245
  Complete submission text file 0001193125-25-185355.txt   1440956

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qdel-20250821.xsd EX-101.SCH 2860
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE qdel-20250821_lab.xml EX-101.LAB 17233
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qdel-20250821_pre.xml EX-101.PRE 10818
18 EXTRACTED XBRL INSTANCE DOCUMENT d912844d8k_htm.xml XML 3525
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-41409 | Film No.: 251241286
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)